Диссертация (1174225), страница 55
Текст из файла (страница 55)
297, N 4. – P.1043-1057.283. Nisenblat V., Bossuyt P.M.M., Shaikh R. et al. Blood biomarkers for the noninvasive diagnosis of endometriosis. // Cochrane database Sys№ Rev. – 2016. – №5. –P.CD012179.284. Nishihara №, Matsumoto K., Hosoi Y., Morimoto Y. Evaluation of antioxidantstatus and oxidative stress markers in follicular fluid for human in vitro fertilizationoutcome // Reprod.
Med. Biol. – 2018. – Vol. 17, N 4. – P.481-486.285. Oh S.R., Choe S.Y., Cho Y.J. Clinical application of serum anti-Müllerianhormone in women. // Clin. Exp. Reprod. Med. – 2019. – Vol. 46, N 2. – P.50-59.286. Oliveira M.A.P., Raymundo №S., Soares L.C.
et al. How to Use CA-125 MoreEffectively in the Diagnosis of Deep Endometriosis. // Biomed Res. In№ – 2017. – Vol.2017. – P.9857196.287. Onwuchekwa C., Oriji V. Hysterosalpingographic (HSG) pattern of infertility inwomen of reproductive age // J. Hum. Reprod. Sci. – 2017. – Vol. 10, N 3. – P.178.288. Oprescu N.D., Ionescu C.A., Drăgan I. et al. Adnexal masses in pregnancy:perinatal impac№ // Rom. J. Morphol. Embryol. – 2018. – Vol.
59, N 1. – P.153-158.289. Othman E.E.-D.R., Hornung D., Salem H.№ et al. Serum cytokines as biomarkersfor nonsurgical prediction of endometriosis. // Eur. J. Obste№ Gynecol. Reprod. Biol. –2008. – Vol. 137, N 2. – P.240-6.290. Özcan C., Özdamar Ö., Gökbayrak M.E. et al.
HOXA-10 gene expression inectopic and eutopic endometrium tissues: Does it differ between fertile and infertilewomen with endometriosis? // Eur. J. Obste№ Gynecol. Reprod. Biol. – 2019. – Vol.233. – P.43-48.291. Ozgur K., Bulut H., Berkkanoglu M., Coetzee K. Reproductive Outcomes ofSegmented In Vitro Fertilization in Patients Diagnosed with Endometriomas. // J.Minim. Invasive Gynecol. – 2018. – Vol.
25, N 1. – P.105-110.292. Pankhurst M.W. A putative role for anti-Müllerian hormone (AMH) in optimising298ovarian reserve expenditure. // J. Endocrinol. – 2017. – Vol. 233, N 1. – P.R1-R13.293. Pardali E., Sanchez-Duffhues G., Gomez-Puerto M.C., Dijke P.
Ten. TGF-βInduced Endothelial-Mesenchymal Transition in Fibrotic Diseases. // In№ J. Mol. Sci. –2017. – Vol. 18, N 10.294. Park H.J., Kim H., Lee G.H. et al. Could surgical management improve the IVFoutcomes in infertile women with endometrioma?: a review. // Obste№ Gynecol. Sci. –2019. – Vol. 62, N 1. – P.1-10.295. Pasqualotto E.B., Agarwal A., Sharma R.K. et al. Effect of oxidative stress infollicular fluid on the outcome of assisted reproductive procedures. // Fertil.
Steril. –2004. – Vol. 81, N 4. – P.973-6.296. Pasqualotto E.B., Lara L.V., Salvador M. et al. The role of enzymatic antioxidantsdetected in the follicular fluid and semen of infertile couples undergoing assistedreproduction. // Hum. Fertil. (Camb). – 2009. – Vol. 12, N 3. – P.166-71.297. Patel B.G., Lenk E.E., Lebovic D.I. et al.
Pathogenesis of endometriosis:Interaction between Endocrine and inflammatory pathways. // Best Prac№ Res. Clin.Obste№ Gynaecol. – 2018. – Vol. 50. – P.50-60.298. Patrelli №S., Berretta R., Gizzo S. et al. CA 125 serum values in surgically treatedendometriosis patients and its relationships with anatomic sites of endometriosis andpregnancy rate. // Fertil. Steril. – 2011. – Vol.
95, N 1. – P.393-6.299. Pérez-López F.R., Martínez-Domínguez S.J., Viñas A. et al. Endometriosis andgestational diabetes mellitus risk: a systematic review and meta-analysis. // Gynecol.Endocrinol. – 2018. – Vol. 34, N 5. – P.363-369.300. Petraglia F., Arcuri F., Ziegler D. de, Chapron C. Inflammation: a link betweenendometriosis and preterm birth.
// Fertil. Steril. – 2012. – Vol. 98, N 1. – P.36-40.301. Piroli A., Marci R., Marinangeli F. et al. Comparison of different anaestheticmethodologies for sedation during in vitro fertilization procedures: effects on patientphysiology and oocyte competence. // Gynecol. Endocrinol. – 2012. – Vol. 28, N 10. –P.796-9.302. Polak G., Barczyński B., Wertel I. et al.
Disrupted iron metabolism in peritonealfluid may induce oxidative stress in the peritoneal cavity of women with endometriosis.299// Ann. Agric. Environ. Med. – 2018. – Vol. 25, N 4. – P.587-592.303. Polak G., Wertel I., Barczyński B. et al. Increased levels of oxidative stressmarkers in the peritoneal fluid of women with endometriosis // Eur. J. Obste№ Gynecol.Reprod. Biol. – 2013. – Vol.
168, N 2. – P.187-190.304. Porpora M.G., Tomao F., Manganaro L. et al. Impaired uterine artery flowassociated with the presence of ovarian endometrioma: preliminary results of aprospective study. // J. Ovarian Res. – 2014. – Vol. 7. – P.1.305. Rahaman M.M., Nguyen A.№, Miller M.P. et al. Cytochrome b5 Reductase 3Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling. // Circ. Res.
–2017. – Vol. 121, N 2. – P.137-148.306. Regiani №, Cordeiro F.B., Costa L. do V.№ da et al. Follicular fluid alterations inendometriosis: label-free proteomics by MS E as a functional tool for endometriosis //Sys№ Biol. Reprod. Med. – 2015. – Vol. 61, N 5. – P.263-276.307.Rehmer J.M.,Flyckt R.L.,Goodman L.R.,Falcone №ManagementofEndometriomas. // Obste№ Gynecol. Surv. – 2019. – Vol. 74, N 4. – P.232-240.308. Rizzello F., Coccia M.E. Direct shedding of endometrioma contents through thefollicle rupture: Insight on the pathogenesis of endometriosis.
// Eur. J. Obste№Gynecol. Reprod. Biol. – 2018. – Vol. 223. – P.144-145.309. Robertshaw I.M., Sroga J.M., Batcheller A.E. et al. Hysterosalpingo-contrastsonography with a saline-air device is equivalent to hysterosalpingography only in thepresence of tubal patency // J. Ultrasound Med. – 2016. – Vol. 35, N 6. – P.1215-1222.310. Rolla E. Endometriosis: advances and controversies in classification, pathogenesis,diagnosis, and treatment // F1000Research. – 2019.
– Vol. 8. – P.529.311. Šalamun V., Verdenik I., Laganà A.S., Vrtačnik-Bokal E. Should we considerintegrated approach for endometriosis-associated infertility as gold standardmanagement? Rationale and results from a large cohort analysis // Arch. Gynecol.Obste№ – 2018. – Vol. 297, N 3. – P.613-621.312. Sampson J.A. Metastatic or Embolic Endometriosis, due to the MenstrualDissemination of Endometrial Tissue into the Venous Circulation.
// Am. J. Pathol. –1927. – Vol. 3, N 2. – P.93-110.43.300313. Sanchez A.M., Vanni V.S., Bartiromo L. et al. Is the oocyte quality affected byendometriosis? A review of the literature // J. Ovarian Res. – 2017. – Vol. 10, N 1. –P.43.314. Sanchez A.M., Viganò P., Somigliana E. et al. The Endometriotic Tissue Liningthe Internal Surface of Endometrioma // Reprod. Sci.
– 2015. – Vol. 22, N 4. – P.391401.315. Santulli P., Chouzenoux S., Fiorese M. et al. Protein oxidative stress markers inperitoneal fluids of women with deep infiltrating endometriosis are increased. // Hum.Reprod. – 2015. – Vol. 30, N 1. – P.49-60.316. Saridogan E., Becker C.M., Feki A. et al. Recommendations for the SurgicalTreatment of Endometriosis. Part 1: Ovarian Endometrioma†‡¶ // Hum. Reprod. Open.– 2017. – Vol. 2017, N 3.317. Schindl M., Birner P., Obermair A.
et al. Increased microvessel density inadenomyosis uteri. // Fertil. Steril. – 2001. – Vol. 75, N 1. – P.131-5.318. Senapati S., Sammel M.D., Morse C., Barnhart K.№ Impact of endometriosis on invitro fertilization outcomes: an evaluation of the Society for Assisted ReproductiveTechnologies Database. // Fertil. Steril.
– 2016. – Vol. 106, N 1. – P.164-171.e1.319. Senapati S., Atashroo D., Carey E. et al. Surgical interventions for chronic pelvicpain // Curr. Opin. Obste№ Gynecol. – 2016. – Vol. 28, N 4. – P.290-296.320. Shen A., Xu S., Ma Y. et al. Diagnostic value of serum CA125, CA19-9 andCA15-3 in endometriosis: A meta-analysis. // J. In№ Med. Res. – 2015. – Vol.
43, N 5.– P.599-609.321.Sikora J.,Smycz-Kubańska M.,Mielczarek-Palacz A.,Kondera-Anasz Z.Abnormal peritoneal regulation of chemokine activation-The role of IL-8 inpathogenesis of endometriosis. // Am. J. Reprod. Immunol. – 2017. – Vol. 77, N 4.322. Sikora J., Mielczarek-Palacz A., Kondera-Anasz Z. Association of the Precursor ofInterleukin-1β and Peritoneal Inflammation-Role in Pathogenesis of Endometriosis.
// J.Clin. Lab. Anal. – 2016. – Vol. 30, N 6. – P.831-837.323. Singh A.K., Chattopadhyay R., Chakravarty B., Chaudhury K. Markers ofoxidative stress in follicular fluid of women with endometriosis and tubal infertility301undergoing IVF // Reprod. Toxicol. – 2013. – Vol. 42. – P.116-124.324. Singh S.S., Suen M.W.H. Surgery for endometriosis: beyond medical therapies //Fertil. Steril. – 2017. – Vol. 107, N 3. – P.549-554.325. Singh V., Mishra B., Sinha S. et al. Role of saline infusion sonohysterography ininfertility evaluation // J. Hum. Reprod.
Sci. – 2018. – Vol. 11, N 3. – P.236.326. Siristatidis C., Askoxylaki M., Varounis C. et al. E-selectin, resistin and reactiveoxygen species levels in GnRH -agonist and -antagonist protocols in IVF/ICSI: aprospective cohort study // J. Assis№ Reprod. Gene№ – 2015. – Vol. 32, N 6. – P.959967.327. Smith R., Smith J.I., Shen X. et al. Patterns of plasma corticotropin-releasinghormone, progesterone, estradiol, and estriol change and the onset of human labor. // J.Clin.
Endocrinol. Metab. – 2009. – Vol. 94, N 6. – P.2066-74.328. Somigliana E. Ovarian reserve, endometriomas, and surgery: research must go on// Fertil. Steril. – 2018. – Vol. 110, N 5. – P.856-857.329. Somigliana E., Viganò P., Benaglia L. et al. Ovarian stimulation and endometriosisprogression or recurrence: a systematic review. // Reprod.
Biomed. Online. – 2019. –Vol. 38, N 2. – P.185-194.330. Somigliana E., Berlanda N., Benaglia L. et al. Surgical excision of endometriomasand ovarian reserve: a systematic review on serum antimüllerian hormone levelmodifications // Fertil. Steril. – 2012. – Vol. 98, N 6. – P.1531-1538.331. Somigliana E., Garcia-Velasco J.A. Treatment of infertility associated with deependometriosis: definition of therapeutic balances // Fertil.
Steril. – 2015. – Vol. 104,N 4. – P.764-770.332. Song Y., Liu J., Qiu Z. et al. Advanced oxidation protein products from thefollicular microenvironment and their role in infertile women with endometriosis. //Exp. Ther. Med. – 2017. – Vol. 15, N 1. – P.479-486.333. Steiner A.Z., Herring A.H., Kesner J.S. et al. Antimüllerian Hormone as aPredictor of Natural Fecundability in Women Aged 30–42 Years // Obste№ Gynecol. –2011. – Vol. 117, N 4.
– P.798-804.334. Stephansson O., Kieler H., Granath F., Falconer H. Endometriosis, assisted302reproduction technology, and risk of adverse pregnancy outcome. // Hum. Reprod. –2009. – Vol. 24, N 9. – P.2341-7.335. Stern J.E., Luke B., Tobias M. et al. Adverse pregnancy and birth outcomesassociated with underlying diagnosis with and without assisted reproductive technologytreatmen№ // Fertil. Steril. – 2015. – Vol.
103, N 6. – P.1438-45.336. Surrey E., Taylor H.S., Giudice L. et al. Long-Term Outcomes of Elagolix inWomen With Endometriosis // Obste№ Gynecol. – 2018. – Vol. 132, N 1. – P.147-160.337.Szubert M.,Suzin J.,Wierzbowski №,Kowalczyk-Amico K.CA-125concentration in serum and peritoneal fluid in patients with endometriosis - preliminaryresults. // Arch. Med. Sci. – 2012. – Vol. 8, N 3. – P.504-8.338.